Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Covington
US Department of Justice
McKesson
Medtronic
Cipla
Johnson and Johnson
Daiichi Sankyo

Generated: May 22, 2018

DrugPatentWatch Database Preview

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Nitrofurantoin (monohydrate/macrocrystals) patents expire, and what generic alternatives are available?

Nitrofurantoin (monohydrate/macrocrystals) is a drug marketed by Amneal Pharms, Mylan, Ranbaxy Labs Ltd, Sandoz, and Watson Labs Inc. and is included in five NDAs.

The generic ingredient in NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.
Drug patent expirations by year for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Pharmacology for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Ingredient-typeNitrofurans
Drug ClassNitrofuran Antibacterial
Synonyms for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
LS-188018
SCHEMBL2508426

US Patents and Regulatory Information for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 207372-001 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 077066-001 Apr 5, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 076648-001 Mar 22, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 076951-001 Mar 30, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Chinese Patent Office
US Army
Johnson and Johnson
Federal Trade Commission
Express Scripts
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.